Researchers from IBEC and IRB Barcelona awarded by “la Caixa” for their pioneering research projects Blog Post

On 16 September, ”la Caixa” Banking Foundation presented the 79 grants for national and international research and innovation projects of excellence. Among the beneficiaries of funding from ”la Caixa” are researchers Eduard Batlle, Raúl Méndez, Meritxell Teixidó and Enrique Marcos, from the Institute for Research in Biomedicine (IRB Barcelona), and José Antonio del Río, Pau Gorostiza and Samuel Sánchez, from the Institute for Bioengineering of Catalonia (IBEC).

 

Dr. Eliandre de Oliveira, cientific leader of the B·Debate on clinical proteomics Blog Post

World leaders in proteomics will meet at CaixaForum Barcelona on 7 and 8 November in an event held by B·Debate, an initiative by Biocat and Obra Social ‘la Caixa’, co-organized in this edition by Barcelona Science Park (PCB), ProteoRed-ISCIII, Bellvitge Biomedical Research Institute (IDIBELL), Centre for Genomic Regulation (CRG) and Vall d’Hebron Institute of Oncology (VHIO). Four experts of renowned prestige in this field –including Dr. Eliandre de Oliveira, head of the PCB’s Proteomics Platform– will lead the debate.

 

Salvador Aznar Benitah receives the VI National ‘Doctores Diz Pintado’ Cancer Research Prize Blog Post

ICREA researcher and group leader of the Stem Cells and Cancer Laboratory at IRB Barcelona, Salvador Aznar Benitah, has been awarded the VI National ‘Doctores Diz Pintado’ Cancer Research Prize. Last Saturday, he received the award during the academic session held by the University of Salamanca. The prize acknowledges Salvador Aznar Benitah’s contributions to transferring knowledge from basic to clinical research.

 

Developmental biology offers the key to finding solutions for paediatric cancer, metastasis, and regeneration Blog Post

From today and until Wednesday,  around 20 speakers from around the world and 150 participants will debate cutting-edge research into plasticity and cell migration—two key aspects in paediatric cancer, metastasis, and regeneration, at the Institut d’Estudis Catalans on the occasion of the 18th Barcelona Biomed Conference, an event organised by the Institute for Research in Biomedicine (IRB Barcelona) –based at PCB– with the support of the BBVA Foundation.

 

The Ordesa Foundation allocates 300,000 euros to charity projects for disadvantaged children Blog Post

The Ordesa Foundation has given the Ordesa 2015 grants, endowed with a total of 300,000 euros. A large part of this amount will be allocated to six projects aimed to address the most disadvantaged childhood and motherhood population in the world. As a novelty, this edition has added a new category aimed at twenty initiatives aimed at children at social risk in Spain which will receive a grant of 5,000 euros each. This´s year call will also donate 10 tons of baby food to social institutions that cater to families without resources. Since 2007 Ordesa has a R+D+I Center at PCB from which it takes an active role in clinical studies and national and international programs to improve the health and quality of citizens, especially during the maternal-child stage. 

 

Atrian Bakers’s bread Tritordeum, made with the new cereal Agrasys, nominated to the Carrefour Innovation Awards Blog Post

A new type of bread  produced by Atrian Bakers  and made with Tritordeum,  has been nominated for the 2015 Carrefour Innovation Awards. The new type of bread will be subjected to population vote until the 21st of June. Tritordeum cereal is the first man-made cereal without genetic modification suitable for human consumption. Developed in the late 70s by a group of scientists from the Institute for Sustainable Agriculture (IAS) of the Higher Council for Scientific Research (CSIC)), and after 30 years of research, Agrasys -a spin-off company based at the Barcelona Science Park, founded by researchers from the IAS and the industry, launched the new bread to the market in April 2013.